A monolith purification process for virus-like particles from yeast homogenate. by Burden, CS et al.
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Monoliths  are  an  alternative  stationary  phase  format  to  conventional  particle  based  media  for  large
biomolecules.  Conventional  resins  suffer  from  limited  capacities  and  ﬂow  rates  when  used  for  viruses,
virus-like  particles  (VLP)  and other  nanoplex  materials.  The  monolith  structure  provides  a more  open  pore
structure  to  improve  accessibility  for  these  materials  and  better  mass  transport  from  convective  ﬂow  and
reduced pressure  drops.  To  examine  the  performance  of  this  format  for bioprocessing  we  selected  the
challenging  capture  of a  VLP  from  clariﬁed  yeast  homogenate.  Using  a  recombinant  Saccharomyces  cere-
visiae  host  it was  found  hydrophobic  interaction  based  separation  using  a hydroxyl  derivatised  monolith
had the  best  performance.  The  monolith  was  then  compared  to  a known  beaded  resin  method,  where
the  dynamic  binding  capacity  was  shown  to  be  three-fold  superior  for the  monolith  with  equivalent  90%
recovery  of  the  VLP.  To  understand  the  impact  of  the  crude  feed  material  confocal  microscopy  was used
to visualise  lipid  contaminants,  deriving  from  the  homogenised  yeast.  It  was  seen  that  the  lipid  formed  a
layer  on  top  of  the  column,  even  after  regeneration  of the  column  with  isopropanol,  resulting  in increas-
ing pressure  drops  with  the  number  of  operational  cycles.  Removal  of  the  lipid  pre-column  signiﬁcantly
reduces  the amount  and  rate  of this  fouling  process.  Using  Amberlite/XAD-4  beads  around  70%  of  the
lipid  was  removed,  with  a  loss  of  VLP  around  20%. Applying  a  reduced  lipid  feed  versus  an  untreated  feed
further  increased  the dynamic  binding  capacity  of  the monolith  from  0.11  mg/mL  column  to 0.25  mg/mL
column.
. Introduction
Chromatography is a commonly used method in the puriﬁcation
f biologics, with the market dominated by conventional parti-
le based resins. But with large nanoplexes, such as viruses and
NA, these resins show low capacities and long processing times
s titres are typically relatively low. To improve the limited capac-
ty of large particles, companies produced resins with smaller bead
izes, however the consequence is a higher resistance to the ﬂow
f the mobile phase [1].  The 1990s saw the development of solid
hases designed for nanoplexes based on membranes [2–4] and
onoliths for viruses and plasmid DNA [5–9].
Research on the ﬁrst monoliths appeared around 1967 but
as abandoned before it was revived in the late 1980s. The
rst commercial columns from BIA separations called CIM (Con-
ective Interaction Media) disks were on the market in 1998.
he stationary phase of monoliths is formed from a continuous
orous material and can be in the shape of disks or columns.
he characteristics of monoliths are a high porosity allowing mass
ransport by convection, low pressure drops and a good capacity for
∗ Corresponding author.
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nanoplexes [1,10,11]. Particle based absorbents require the trans-
port of molecules though their pores via diffusion, this can be slow
or even prevent large molecules accessing the large internal surface
area. The open pore structure in monoliths uses ﬂow to improve the
mass transfer to the sites of adsorption [12].
Hence monoliths exhibit ﬂow-independent performance and
can run over a range of ﬂow rates, which would be unachievable
with a conventional resin column, indicating that the adsorption
is not mass transfer limited. The advantages of this can be seen in
reduced processing times, although the ﬂow rate becomes limited
by the high-pressures formed at very high rates [10,13,14].  Scale
up of the monolith based columns is complex as the manufactur-
ing process is highly exothermic, resulting in the possibility of an
inhomogeneous structure [11]. Therefore monoliths are changed
from axial ﬂow in the disks to radial ﬂow in the larger columns [1].
Columns of up to 8 L have been produced this way for a commercial
plasmid DNA process [8].
Virus-like particles (VLP) are a proven alternative to viral vac-
cines, their success is in part due to the fact that they contain no
genetic material but mimic  the overall structure of virus particles
[15]. This still causes the immune response needed to induce pro-
tection in the patient but with fewer health risks over the classic
attenuated, or inactivated viral vaccines [16]. Currently two types
of VLP vaccines are available on the market against the hepatitis
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Fig. 2. Flow sheet of primary puriﬁcation and pre-chromatography preparation
steps adapted from [32]. The VLP is produced as intracellular product in recom-
binant Saccharomyces cerevisiae and the detergent Triton X-100 cleaves it off the
endoplasmic reticulum. Removal of the detergent is with Amberlite (XAD-4) before
ﬁltration prior to being placed on the column. Material can then follow two different
routes; route one is for crude material and is ﬁltered before the column, route twoig. 1. A schematic diagram of the virus-like particle HBsAg from yeast. Each VLP i
nd  25% lipid. The core of the VLP contains free host lipids.
 virus (HBV) and the human papilloma virus (HPV). The hepatitis
accine is composed of a VLP based on the hepatitis B surface anti-
en (HBsAg). It can be produced recombinantly in yeast, such as
accharomyces cerevisiae [17–21] or mammalian cells [22]. It buds
rom the endoplasmic reticulum as a 22 nm lipoprotein (Fig. 1)
omposed of 25% protein and 75% lipid [23].
Puriﬁcation of the VLP is possible using chromatographic sepa-
ation with a weak hydrophobic interaction media, such as Butyl-S
epharose 6 Fast ﬂow [24,25].  The use of complex homogenised
eeds can cause fouling during consecutive chromatography runs
esulting in reduced dynamic binding capacities and earlier break-
hroughs [26–28].  Using a homogenised and clariﬁed crude S.
erevisiae feed, containing the HBsAg VLP, Jin et al [24] saw fouling
ffects from the lipid released during the detergent VLP liberation
tep during puriﬁcation. Pretreatment of the feed before loading on
o the column can greatly reduce the effect of fouling [26,29] which
an be visualised using confocal microscopy [24,30] to conﬁrm the
osition and degree of fouling.
In this paper the chromatographic process was  successfully
ransferred to a hydrophobic interaction monolith. A lipid removal
tep was then introduced into the current puriﬁcation process for
he VLP (see Fig. 2), after screening for a suitable lipid removal
ethod. The dynamic binding capacity of the monolith was com-
ared with crude and reduced lipid feeds to highlight the effect of
lariﬁcation on the feed.
. Materials and methods
All chemicals were purchased from Sigma–Aldrich (Poole, UK)
nless stated.
.1. Fermentation
The virus-like particle (HBsAg) was produced using a recombi-
ant S. cerevisiae.  Cultures were grown in three stages; stages 1 and
 were in shake ﬂasks on a rotary shaker for 24 h and stage 3 was
n a 75 L fermenter (Inceltech High containment fermenter, Maid-
nhead, UK) for 72 h. The full process and media components are
is  for a reduced lipid feed where a lipid removal method is applied before ﬁltration.
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etailed in [31]. Glucose and galactose was monitored off-line (YSI
K, Hampshire, UK) along with OD600 and dry cell weight. Cells
ere harvested at 72 h and centrifuged at 15,000 rpm at a ﬂow rate
f 1 mL/min using a tubular bowl centrifuge (CARR Powerfuge P6,
neumatic Scale Corporation, FL, USA). The cell paste was  stored at
80 ◦C.
.2. Puriﬁcation process
The primary puriﬁcation process carried out is detailed in Fig. 2
nd was adapted from Kee et al. [32], Frozen cell paste was resus-
ended at 25% (w/v) in 0.1 M sodium phosphate, 0.5 M sodium
hloride and 2 mM phenylmethylsulfonyl ﬂuoride (dissolved in iso-
ropanol). Cell disruption was carried out in a homogeniser at
200 bar for three passes (Gaulin Micron Lab 40, APV Gaulin GmbH,
ermany) or 400 bar for eight passes (Lab 60). The detergent Tri-
on X-100 was added to the homogenate to a ﬁnal volume of 0.4%
v/v) and incubated for 4 h at 20 ◦C. Centrifugation was carried out
t 3000 × g for 5 min  to remove cell debris. Removal of the Triton
-100 was by XAD-4 beads in a batch mode at 0.5 g Triton per g
AD-4 (in accordance to values speciﬁed on Sigma product infor-
ation sheet) for 2 h at 20 ◦C. This was followed by ﬁltration to
emove the beads at 1.0 m and 0.7 m (Whatman, Kent, UK).
.3. Lipid removal protocol
Lipid removal was carried out in a batch process using mate-
ial which was prepared from the puriﬁcation process. For the
mmonium sulphate precipitation saturated solutions were added
o the sample in equal volume with the crude yeast material.
amples were mixed for 20 min  and then spun at 14 K rpm for
0 min  to remove any precipitate. Both lipid removal absorbent
LRA) (Advance Mineral Corp, CA, USA) and XAD-4 (Amberlite) were
dded at the relevant (w/v) concentrations to the sample and mixed
or 30 min. The sample was then ﬁltered with a 1.0 m ﬁlter (What-
an, Kent, UK) to remove the LRA and XAD-4. Cuno Zeta Plus® BC25
apsule ﬁlters (Cuno 3 M,  Bracknell, UK) were run at varying ﬂow
ates using an AKTA Crossﬂow system controlled by Unicorn ver-
ion 4.0 (GE Healthcare, Bucks, UK). Filters were equilibrated with
 solution of equal parts homogenisation buffer and 0.01 M sodium
hosphate, pH 7.0 at a 1:1 ratio. A new ﬁlter was used at each ﬂow
ate. All ﬁltrates and the supernatants were collected and analysed
or VLP and lipid levels.
.4. Hydrophobic interaction chromatography (HIC)
The monolithic chromatographic process was carried out using
IM® 0.34 mL  disk or 1 mL  column monoliths (BIA Separations,
lovenia) with either C4 or OH ligands. Flow of the mobile phase
nd sample in the disks is axial, whereas the 1 mL column is tube
hape and the ﬂow is radial. The method was adapted from work
y Jin et al. [24]. Buffer conditions were (unless stated) as fol-
ows; Buffer A, 20 mmol−1 sodium phosphate, 1.0 M ammonium
ulphate, pH 7.0; Buffer B, 20 mmol−1 sodium phosphate, pH 7.0;
uffer C, 30% isopropanol in Buffer B. Cleaning-in-place was with
 M sodium hydroxide. The samples were ﬁltered with a 0.45 m
lter (Millipore, UK) and then equilibrated to the salt level in Buffer
 by adding ammonium sulphate to the feed. Feed volumes were
djusted depending on column size and material type, with 2 mL  for
he 0.34 mL  disks and 5 or 10 mL  for the 1 mL  columns for the lipid
nd reduced lipid feed, respectively. The 1 mL  columns were equi-
ibrated with 20CV of Buffer A followed by loading and a wash step
otalling 20 or 25CV. Elution was carried out with 10CV of Buffer B,
ith regeneration of the columns using Buffer C for 10CV to remove
ightly bound material. A CIP was carried out after every run, which
as followed by a water wash. The 0.34 mL  columns were loadedgr. B 880 (2012) 82– 89
and washed with Buffer A for 10CV, elution with buffer B was for
7CV and regeneration with Buffer C for 10CV. All chromatogra-
phy was  carried out on an AKTA Explorer 100 system controlled
with Unicorn Version 4.0 (GE Healthcare, Bucks, UK)  and monitored
using 280 nm.
The Butyl-S HiTrap 1 mL  columns were run on the same system
using the method from Jin et al. [24]. Columns were run at 1 mL/min
with 0.6 M ammonium sulphate in Buffer A. Buffers B and C were
the same as above, and the columns were cleaned with 0.5 M NaOH.
2.5. Enzyme linked immunosorbent assay (ELISA) for VLP
Quantiﬁcation of the VLP was carried out using the Abbott-
Murex HBsAg Version 3 96-well plate ELISA kit (Dartford, UK).
An HBsAg standard was  obtained from Aldevron GENOVAC GmbH
(Freiburg, Germany). Samples were pre-diluted 1000 fold before
use to lie within the calibration range.
2.6. Lipid analysis by HPLC
To identify and quantify the type and amounts of lipids present
a Jordi Gel Glucose-DVB 500 A˚ column (Grace, Lancashire, UK) was
used as stated in Jin et al. [24]. Samples were applied to the col-
umn  using a mobile phase of chloroform, methanol and 0.15% TFA
(in water) in the ration 50:43:7. Samples were prepared by adding
70 L of the required sample to 930 L of extraction solution, which
is the same composition as the mobile phase without water. Mix-
tures was centrifuged 30 min  after extraction solution addition to
removal any solids. The column was operated at 1 mL/min on an
Agilent 1100 HPLC system (Wokingham, UK) with an injection vol-
ume  of 50 L. After the column samples were passed through an
Evaporative Light Scattering detector (ELSD, Grace) operating at
39.8 ◦C, a gas ﬂow of 1.4 mL−1 and gain 1.
2.7. Electron microscopy
Chromatography elution samples were concentrated and diaﬁl-
tered with 0.01 M PBS pH 7 using 7 mL  Pierce protein concentrators,
MWCO  150,000 (Thermo Scientiﬁc, Loughbough, UK). Electron
microscopy was carried out at UCL department of Cell and Devel-
opmental biology, using a JEOL 1010 transmission electron micro-
scope (Jeol, UK). Samples were placed onto a carbon grid and the
sample was  left to dry. The carbon grid was stained with 2% uranyl
acetate for approximately 1 min. The grid was  viewed at 300K×.
2.8. Confocal microscopy
Neutral lipids were labelled with BODIPY 493/503 dye solution
(Invitrogen, Paisley, UK) to give a ﬁnal ratio of 8 mol  L−1 g−1 lipids.
The solution was incubated at 20 ◦C overnight before use. The C4
monolith disks (0.34 mL)  were challenged for 3 chromatography
runs with a crude feed containing the ﬂuorescently labelled lipids.
Images were acquired using a confocal microscope (Pseemore
upright SP1, Leica Microsystem GmbH, Mannheim, Germany) with
a 10× objective lens.
2.9. Atomic force microscopy
Glass slides were cleaned with ethanol and silanised with
trichloro (1H, 1H, 2H, 2H-perﬂuoroctyl) silane vapours to make it
hydrophobic and encourage the VLP to bind to the surface. The
silanised glass slides were attached to magnetic holders (Agar
Scientiﬁc, UK) using a protocol from Müller and Engel [33]. The
glass slide with the VLP was prepared in a similar method to
that stated by Milheit et al. [34], with the VLP samples con-
centrated and diaﬁltered into Tris–HCl 20 mM,  NaCl 150 mM,  pH
C.S. Burden et al. / J. Chromatogr. B 880 (2012) 82– 89 85
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Fig. 3. Chromatograms obtained during screening for a suitable monolith column ligand with post-hydrophobic interaction chromatography material. Material loaded on to
C4  and OH column at 0.6 M (NH4)2SO4 and 0.3 M (NH4)2SO4 to adjust binding afﬁnities within in the column. Absorbance proﬁles at 280 nm are shown with peaks marked
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aut  for (L) Loading Zone; (E) Elution Zone and (R) Regeneration. Graphs correspond
4  disks, (C) 50% C4 and 50% OH 1 mL  monolith columns and (D) OH 1 mL  monol
eparations.
.4, using 7 mL  Pierce protein concentrators (Thermo Scientiﬁc,
oughbough, UK). The VLP was incubated onto the glass slides,
or two hours and ﬁxed with 5% glutaraldehyde. AFM was  per-
ormed in a tapping/intermittent mode using a Multimode SPM
Veeco, Mannheim, Germany), with a J scanner and NSC15 can-
ilevers (Mikromasch, Estonia) and Nanoscope 5.3 software.
. Results and discussion.1. Use of monoliths for VLP separation
The current chromatographic method of VLP separation uses
 weak hydrophobic ligand, as the VLP is strongly hydrophobic. high ligand density (HLD) C4 1 mL monolith columns, (B) low ligand density (LLD)
lumns. Columns A/B/D are commercially available. Column C was  a gift from BIA
The puriﬁcation process was transferred to a 1 mL  poly (butyl
methacrylate-co-ethylene diamethacrylate) monolith chromatog-
raphy column and subsequently the salt levels in binding were
then studied to maximise binding and recovery. Three commer-
cially available columns with high density C4, low density C4 and
hydroxyl (OH) ligands were selected as well as a prototype column,
with 50% C4 butyl and 50% OH ligands. Crude yeast containing the
VLP was prepared using the puriﬁcation process (Fig. 2) and passed
through a Butyl-S 6 Sepharose FF column. The elution fraction con-
taining the VLP from the column was loaded on to the monoliths at
0.6 M or 0.3 M ammonium sulphate. If the elution peak was smaller
than the peak for the regeneration step this was an indication that
the VLP had bound too tightly to the column and was only being
86 C.S. Burden et al. / J. Chromatogr. B 880 (2012) 82– 89
Table  1
Recoveries of VLP obtained during initial screening experiments with C4 and OH
columns using puriﬁed VLP and 0.6–0.3 M ammonium sulphate.
Column type 0.6 M (NH4)2SO4
Recovery of VLP (%)
0.3 M (NH4)2SO4
Recovery of VLP (%)
High ligand density C4 2–5 1–3
Low ligand density C4 40–50 20–23
50% C4 and 50% OH ligands 0–1 0–1
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Fig. 4. Comparison of dynamic binding capacity of butyl-S Sepharose 6 FF (GE
Healthcare) 1 mL  HiTrap column () and a monolith OH 1 mL column (BIA Sepa-
F
T
oHydroxyl ligands 85 –
Butyl-S Sepharose 6 FF [24] 90 –
emoved using isopropanol in the regeneration buffer. The iso-
ropanol renders the VLP unusable and so the amount of VLP lost to
his fraction must be minimised. Reducing the amount of salt in the
oading buffer decreases the binding afﬁnity of the VLP to the col-
mn which helps to reduce the VLP being lost in the regeneration
tep.
The three columns with the C4 ligands proved to be unsuit-
ble for the puriﬁcation of the VLP (Fig. 3A–C). The reduction in
he ligand density from high Fig. 3A to low Fig. 3B did result in
n increased amount of VLP eluted from the column but recovery
as only around 45% (see Table 1) with most VLP was  removed
rom the column in the regeneration step. Reducing the salt level
o 0.3 M resulted in a lower amount of VLP eluted, possibly as the
ow salt did not promote sufﬁciently strong binding. The column
rom Fig. 3C was the prototype column using 50% C4 ligands with
0% OH ligands. Although this column theoretically should have
he lowest hydrophobicity of the three columns with C4 ligands
t was evident during use that it still retained high hydrophobic
roperties.
The only column to perform the puriﬁcation effectively, with
ecoveries around 85% was  the OH column (Fig. 3D), which is com-
arable to the Butyl-S 6 Sepharose FF column (Fig. 3E and Table 1).
his column has the weakest hydrophobicity and exhibits some
ydrophilic properties. By increasing the amount of salt in the load-
ng buffer from the initial level of 0.6 M to 1.0 M recoveries of around
0% were obtained. Compared to the current bead based process
he monolith had a dynamic binding capacity for the VLP that was
ig. 5. Confocal microscopy showing the fouling of lipids in a C4 disk monolith. The lipids
he  column was  challenged with the labelled crude VLP material; (2) the column was  cut 
n  top of the column, causing an increase in pressure and reducing the recovery and (3ii)rations) (). The columns were loaded with untreated homogenised yeast and the
VLP  breakthrough was  monitored using ELISA (n = 2 for butyl-S column and n = 3 for
OH monolith. Error bars are 1 S.D).
approximately three to four times larger when challenged with
untreated yeast homogenate (see Fig. 4).
3.2. Lipid fouling in monoliths
Fouling and column regeneration is a major issue in chromatog-
raphy often resulting in a reduction in dynamic binding capacities,
increasing pressure drops and rapidly decreasing the life span of the
column. Lipids are a particularly difﬁcult foulant to control as they
often bind irreversibly and cannot be removed easily though clean-
ing methods. Confocal microscopy is a useful tool to visualise the
degree and position of fouling on chromatography resins [24,30].
Using a method adapted from Jin et al. [24], a C4 monolith disk
was  run in a bind-elute mode with a feed containing ﬂuorescently
labelled neutral lipids. The use of a C4 ligand on the monolith and
not the OH ligand allowed the formation of the fouling to occur
 were ﬂuorescently labelled with BODIPY 493/503 dye (Invitrogen, Paisley, UK). (1)
into sections and placed under the confocal microscope; (3i) the lipids form a layer
 the lipids move throughout the column too, affecting the VLP recovery.
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F cation material to determine the amount of depletion and the VLP retained. The level of
l d analysed by ELISA. The four methods were (a) ammonium sulphate precipitation; (b)
l
a
b
w
s
a
a
l
p
o
o
w
T
t
t
p
l
d
3
t
a
Fig. 7. Comparison of the VLP breakthrough curves of 1 mL  hydroxyl monoliths with
a  crude () and reduced lipid material (). The reduced lipid feed was prepared
by  adding 0.3 g/mL of Amberlite/XAD-4 for 30 min at 20 ◦C to the crude material.ig. 6. Comparison of the four lipid removal methods tested on post primary puriﬁ
ipid  was  determined by evaporative light scattering detection and the VLP retaine
ipid  removal absorbent (LRA); (c) Amberlite/XAD-4 and (d) Cuno ﬁlters.
t a faster rate and therefore enable a more deﬁned distinction
etween fouled areas under the confocal microscope. The column
as removed from the supporting ring around it and sliced into thin
ections with a razor blade. A vertical cross-section was placed on
 microscope slide for visualisation under the confocal microscope
nd 1 mm  sections were captured across the column. A distinct
ayer of lipids was seen on the top of all the sections analysed, com-
ared with the middle and lower sections which had a lower degree
f ﬂuorescence (Fig. 5). The build up of lipids suggests that the top
f the disk acts to capture a portion of the lipids and lipid micelles
hile still allowing some to deposit in the main body of the disk.
his build up causes an increase in the pressure drop experienced by
he column over successive runs (results not shown) which reduces
he number of runs the column can be used for as the maximum
ressure is quickly reached. Consecutive runs with the OH mono-
ith sees a slower but still highly signiﬁcant increase in the pressure
rop over the column.
.3. Lipid removal methods from pre-chromatography feedThe lipids in the feed are released during homogenisation of
he yeast cells at high pressure and the detergent step to liber-
te the VLPs from the membranes of the endoplasmic reticulum,
Binding was under 1 M (NH4)2SO4 pH 7 at 3 mL/min. Points represent triplicate
runs.
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Fig. 8. Pictures of HBsAg from elution samples after hydrophobic interaction chromatography using an OH monolith. The black bar is equal to 100 nm on both pictures. (A)
Transmission electron microscope (TEM). Samples were negatively stained with 2% uranyl acetate on carbon grid. (B) Atomic force microscopy picture (AFM). Samples were
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2dhered to a silanised glass slide. AFM was in tapping mode.
hich also causes the release of lipids from the yeast debris.
emoval of lipids before the chromatography step can help increase
he binding capacity and lifetime of a column [24]. Four meth-
ds were chosen to evaluate the amount of lipid removed and
LP retained; (1) ammonium sulphate precipitation [29], (2) lipid
emoval absorbent (LRA), (3) Cuno Zeta Plus ﬁlters [29] and (4)
AD-4 (Amberlite). The methods were applied in batch mode to
aterial which had completed the primary puriﬁcation process
etailed in Fig. 2.
Solutions of varying ammonium sulphate saturations were
dded to crude feed material, with levels up to 35% (w/v) (Fig. 6a).
ipid reduction does not occur until the saturation level of ammo-
ium sulphate is at or above 20% (w/v), with around 75% lipid
emoval achievable. But the reduction in lipid also coincides
ith a loss of VLP, with complete removal occurring at 35%
w/v), suggesting that the VLP precipitates in a similar way  to
he lipids. Lipid removal absorbent (LRA) media is a synthetic
alcium silicate hydrate adsorbent which is effective for lipids,
ipopolysaccarides and lipoproteins. Reduction in lipid levels cor-
esponded to a similar reduction in the amount of VLP which
emained (Fig. 6b), suggesting that co-removal occurred. As the
LP is essentially a lipoprotein, this reduction is understand-
ble.
The other two methods were more effective at removing lipids
hile retaining high levels of VLP. Levels of the VLP recovery
ere at 80% or greater, showing a distinct advantage over the
ther two methods. Cuno Zeta Plus Filters are depth ﬁlter cap-
ules using diatomaceous earth as an adsorbent. Three different
ow rates, 6.5/20/65 mL/min were chosen to study their perfor-
ance (Fig. 6d). At 6.5 mL/min the greatest reduction in lipid was
een, as expected due to the longer residence time, although the
ighest amount of VLP was also retained. An increase in ﬂow rate
0 fold to 65 mL/min only decreased the amount of lipid removed
nd VLP retained by approximately 10%, showing that this method
s robust. The use of XAD-4 (Amberlite) adsorbent was the most
ffective method, with a VLP to lipid ratio of 4 compared to the ﬁl-
ers which had a ratio of 2 (Fig. 6c). Hence XAD-4 was  selected to
roduce a reduced-lipid feed for the puriﬁcation protocol. XAD-4
s a polyaromatic adsorbent for small hydrophobic compounds and
s currently used in our primary puriﬁcation protocol to removed
riton X-100, enabling it to be easily integrated into the process.
he results indicate that the adsorbent has a good speciﬁcity for
ipids in the feed. At 0.3 g/mL the amount of lipids in the feed
as signiﬁcantly reduced by around 70% but had little impact on
he VLP remaining, ensuring that the loss of VLP was  less than
0%.3.4. Effect of lipid removal on chromatography process
To determine the effect of the lipid on the performance of the
monolith two  1 mL  OH columns were challenged with either an
untreated or reduced lipid crude feed (Fig. 2), using the XAD-4 pro-
cedure. The runs were carried out with fresh OH columns using 1 M
(NH4)2SO4 at 3 mL/min and 1 mL  samples were taken to determine
the binding capacity of the column. The lipid feed had a 10% break-
through point of 4CV, whereas the reduced lipid feed had a 10%
breakthrough of 10CV (Fig. 7). These results show that the reduced
lipid feed increases the capacity of the monolith column to bind
the VLP. This implies that the lipid competitively binds with VLP
to the OH ligand resulting in the much reduced capacity when an
untreated feed is used; the same effect will happen with conven-
tional resins using butyl-S resins [24].
Elution samples were examined under electron microscopy and
atomic force microscopy to investigate the composition of the VLP
after it has been though an OH monolith. Both techniques show a
majority of circular VLP particles and a few larger masses (Fig. 8A
and B). The VLP was found to be around 30–35 nm under TEM and
around 25–30 nm with AFM. These differences in size may  be due to
the different techniques used to capture the VLP onto the sampling
surface and it is unknown what effects they have on the struc-
ture of the VLP. The TEM sample was dried onto the carbon grid
and resulted in the VLP being condensed together, whereas AFM
involved a hydrophobic surface. Both methods indicate that most
of the VLP is in monomeric form, although no distinct topography
can be seen, and the sizes of the particles correlate to that in the
literature [34].
4. Conclusion
The above study shows that the VLP (HBsAg) can be successfully
puriﬁed by hydrophobic interaction using a monolith format. The
use of a weakly hydrophobic interaction OH ligand gave the best
performance. This is due to the highly hydrophobic nature of the
VLP which binds too strongly to more hydrophobic chemistries.
Lipids, a common contaminant in biological material can cause
serious column fouling issues, proving hard to remove during
regeneration. Within the monolith lipids can cause pressure issues
due to deposition and build up on the surface of the monoliths, and
reduces the column life of the monolith. Reduction of the lipid lev-
els results in slower pressure increases indicating a reduced rate of
fouling. The capacity of the monolith is also improved by remov-
ing around 70% of the lipids using XAD-4 beads in a simple batch
omato
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